Coronary artery disease (CAD), acute coronary syndrome (ACS), and heart failure (HF) are
major global health issues with high morbidity and mortality rates. Biomarkers like cardiac …

Cerebrovascular disease is the leading cause of long-term disability in the world and the
third-leading cause of death in the United States. The early diagnosis of transient ischemic …

Objectives. The study evaluated the association between lipoprotein‐associated
phospholipase A2 (Lp‐PLA2) gene polymorphisms and coronary heart disease (CHD), in …

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a newly emerging biomarker with
strong pro-inflammatory effects, and is an independent risk predictor of atherosclerotic …

Lipoprotein-associated phospholipase A2 (Lp-PLA2) probably plays an important role in the
development of acute coronary syndrome (ACS). However, alterations of Lp-PLA2 levels …

血清脂蛋白相关磷脂酶A2水平与伴高血压的急性缺血性脑梗死复发正相关- PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

目的: 探讨脂蛋白相关磷脂酶A2 (lipoprotein-associated phospholipase A2, Lp-PLA2),
基质金属蛋白酶9 (matrix metalloproteinase 9, MMP9) 与心肌超声造影的相关性及对急性冠脉 …

As doenças cardiovasculares, incluindo o infarto agudo do miocárdio, representam um
importante problema de saúde pública, apresentando altas taxas de incidência e …

Background Lp‐PLA 2 is a novel inflammation marker in cardiovascular disease. While
several manufactures have registered Lp‐PLA 2 activity reagents, few studies have …

目的探讨脂蛋白相关磷脂酶A2 (Lp PLA2) 活性水平联合肌钙蛋白(cTn) 对急性心肌梗死(AMI)
的早期诊断价值. 方法连续收集2019 年1 月至12 月来我院胸痛中心做冠脉造影的患者182 例 …